LRCX AI Stock Analysis – Buy, Hold, or Avoid?
Lam Research Corporation (LRCX)
Fundamentals
Lam Research (LRCX) demonstrates robust financial and operational execution underpinned by consistently outpacing earnings and revenue expectations over recent quarters. The company exhibits a solid growth trajectory and expanding margins, reflecting strong demand for its semiconductor equipment and technological leadership, though its elevated valuation warrants close attention.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
23.76% YoY
Q1 2026
Net Income
37.18% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.8B | 5.3B | 5.3B | 5.2B | 4.7B | 4.4B | 4.2B | 3.9B |
| Revenue Growth YoY | +23.76% | +22.14% | +27.74% | +33.58% | +24.43% | +16.44% | +19.70% | +20.71% |
| Net Income | 1.8B | 1.6B | 1.6B | 1.7B | 1.3B | 1.2B | 1.1B | 1.0B |
| Net Income Growth YoY | +37.18% | +33.83% | +40.51% | +68.59% | +37.78% | +24.81% | +25.81% | +27.13% |
| EPS | $1.46 | $1.27 | $1.24 | $1.35 | $1.04 | $0.93 | $0.86 | $0.78 |
| EPS Growth YoY | +40.38% | +36.56% | +44.19% | +73.08% | +40.54% | +27.40% | +28.36% | +30.00% |
Profitability Metrics
Technical Analysis
LRCX is currently in a strong uptrend with price well above key moving averages and showing a golden cross, signaling sustained bullish momentum. The RSI is neutral, suggesting no immediate overbought conditions, while theADX indicates a weak trend strength suggesting potential for consolidation or sideways movement soon. The stock is near its 52-week high, with strong institutional accumulation evident, indicating favorable technical conditions for buyers.
No extreme reading
Price in uptrend
Trend developing
50 above 200 - bullish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Lam Research (LRCX) demonstrates robust financial and operational execution underpinned by consistently outpacing earnings and revenue expectations over recent quarters. The company exhibits a solid growth trajectory and expanding margins, reflecting strong demand for its semiconductor equipment and technological leadership, though its elevated valuation warrants close attention.
Latest Earnings
Q1 2026 Earnings (Mar 29, 2026)
Earnings Per Share (EPS)
Actual
$1.47
Estimated
$1.36
Surprise
+$0.11
Surprise %
+8.09%
Revenue
Actual
$5.84B
Estimated
$5.75B
Surprise
+$91.14M
Surprise %
+1.58%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $1.47 | $1.27 | $1.26 | $1.33 | $1.04 | $0.91 | $0.86 | $0.81 |
| EPS (Estimated) | $1.36 | $1.17 | $1.22 | $1.21 | $1.00 | $0.88 | $0.81 | $0.76 |
| EPS Surprise | +$0.11 | +$0.10 | +$0.04 | +$0.12 | +$0.04 | +$0.03 | +$0.05 | +$0.05 |
| % Diff | +8.1% | +8.5% | +3.3% | +9.9% | +4.0% | +3.6% | +6.2% | +6.9% |
| Revenue | ||||||||
| Revenue (Actual) | $5.84B | $5.34B | $5.32B | $5.17B | $4.72B | $4.38B | $4.17B | $3.87B |
| Revenue (Estimated) | $5.75B | $5.23B | $5.22B | $5B | $4.64B | $4.32B | $4.06B | $3.82B |
| Revenue Surprise | +$91.14M | +$111.56M | +$101.04M | +$167.42M | +$77.41M | +$58.58M | +$110.66M | +$49.21M |
| % Diff | +1.6% | +2.1% | +1.9% | +3.3% | +1.7% | +1.4% | +2.7% | +1.3% |
Valuation
Lam Research (LRCX) trades at premium valuation multiples reflecting strong growth prospects and leadership in the semiconductor capital equipment sector. Robust revenue and earnings growth, coupled with high profitability and solid financial health, underpin this valuation. However, elevated multiples suggest much of the growth optimism is already priced in, requiring continued execution and industry tailwinds to justify current levels.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 34.22 | 34.75 | 26.42 | 18.03 | 17.53 | 19.49 | 23.74 | 34.15 |
| Price to Sales | 42.77 | 41.45 | 31.13 | 23.99 | 19.77 | 21.22 | 25.44 | 36.00 |
| Price to Book | 23.61 | 21.84 | 16.26 | 12.58 | 9.81 | 10.54 | 12.52 | 16.32 |
| Enterprise Value to EBITDA | 114.82 | 110.86 | 83.38 | 65.05 | 55.00 | 61.88 | 73.21 | 107.44 |
| Enterprise Value to Revenue | 42.60 | 41.13 | 30.72 | 23.62 | 19.57 | 21.07 | 25.18 | 35.78 |
Sentiment & Analyst Ratings
The market sentiment for Lam Research (LRCX) is strongly positive, driven by robust earnings, solid revenue growth, and optimistic future guidance in the AI-driven semiconductor sector. Analysts overwhelmingly favor the stock with many recent price target upgrades, while social media buzz highlights strong retail enthusiasm fueled by the AI boom and equipment demand.
Analyst Recommendations
Risk Assessment
Lam Research Corporation (LRCX) exhibits a strong financial position supported by robust liquidity and moderate leverage amid exceptional demand driven by AI and advanced semiconductor fabrication technologies. The company enjoys a leading market share in wafer fabrication equipment with healthy margins and expanding revenue, although it faces cyclicality, geopolitical risks, and sector-specific supply chain vulnerabilities. Overall, the firm presents as a financially sound entity with growth opportunities tempered by industry and geopolitical uncertainties.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q1 2026
Quick Ratio
Latest Quarter: Q1 2026
Debt-to-Equity
Latest Quarter: Q1 2026
Debt-to-Assets
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 2.54 | 2.26 | 2.21 | 2.21 | 2.45 | 2.54 | 2.53 | 2.97 |
| Quick Ratio | 1.77 | 1.61 | 1.60 | 1.55 | 1.64 | 1.73 | 1.74 | 2.00 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 0.35 | 0.44 | 0.44 | 0.45 | 0.47 | 0.57 | 0.59 | 0.58 |
| Debt-to-Assets | 0.18 | 0.21 | 0.20 | 0.21 | 0.22 | 0.25 | 0.26 | 0.27 |
Liquidity Assessment
Current Ratio: 2.54(Strong)
Quick Ratio: 1.77(Strong)
The company has strong liquidity with sufficient short-term assets to cover liabilities.
Solvency Assessment
Debt-to-Equity: 0.35(Low)
Debt-to-Assets: 0.18(Low)
The company maintains a balanced capital structure with manageable debt levels.
Frequently Asked Questions about LRCX
AI Answers: Common Questions About LRCX
Get AI-powered answers to the questions investors ask most about Lam Research Corporation
LRCX is a strong buy for medium- and long-term investors, with a P/E of 55.59 reflecting high growth (revenue up 23.7% YoY, EPS up 58%). While the stock is near its 52-week high ($298), fundamentals and sentiment remain robust, and the premium valuation is justified by industry leadership and margin expansion.
Unless your thesis has changed or you are a short-term trader seeking to lock in gains near resistance ($298), there is little reason to sell. Fundamentals remain strong, technicals are not overbought (RSI 65.9), and earnings momentum continues; only consider trimming if you are concerned about valuation or sector volatility.
The biggest risks are semiconductor industry cyclicality (capex downturns), geopolitical/export controls (notably China revenue exposure), and valuation compression if growth slows. Sentinel notes a moderate risk profile, with a debt-to-equity of 0.35 and liquidity ratios (current >2.5) mitigating financial risk.
Immediate resistance is at $298; a breakout could target $310-$320 if volume confirms. Downside support is at $241 (50 SMA) and $180 (200 SMA). Analyst targets have been raised above $300, reflecting continued optimism.
LRCX is fairly valued given its growth and profitability, with a P/E of 55.59 and EV/EBITDA well above peers. While multiples are high, they are supported by 24% revenue and 40% earnings growth, 50% gross margins, and strong free cash flow; any growth miss could pressure the valuation.
Fundamentals are industry-leading: gross margin near 50%, net margin above 31%, ROE above 65%, and recurring revenue from top-tier chipmakers. The balance sheet is strong, with a current ratio above 2.5 and low leverage.
Technicals are bullish but suggest near-term caution: price is above all major SMAs with a golden cross, but ADX (19.5) signals weak trend strength and possible consolidation. RSI (65.9) is neutral, with support at $241 and resistance at $298.
Key catalysts include upcoming earnings reports, further AI-driven semiconductor capex, potential new product launches, and macro events affecting chip demand or export policy. Watch for volume confirmation on a breakout above $298.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.